Implications of False Positive Serology of Toxoplasma gondii in a Pre-transplant Patient

被引:6
|
作者
Beal, Stacy [1 ]
Racsa, Lori [1 ]
Alatoom, Adnan [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
来源
LABMEDICINE | 2014年 / 45卷 / 01期
关键词
Toxoplasma gondii; false positive IgM; serology;
D O I
10.1309/LMQIB0BPOJ96WGCU
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Patient: A 21-year-old white male with cystic fibrosis. Chief Complaint: Pre-transplant workup in preparation for bilateral lung transplant. Past Medical History: Cystic fibrosis diagnosed at age 3, onset of insulin-dependent diabetes around age 20, and multiple hospitalizations for pulmonary and gastrointestinal complications. Family and Social History: The patient lives with his father and stepmother, has a pet bearded dragon, and has multiple tattoos and piercings. His stepmother has a cat, but he does not clean the litter box. Principal Laboratory Findings: The pre-transplant workup included several tests for infectious diseases, tests of organ function, radiology studies, and markers of malignancy. The only significant finding was a positive Toxoplasma gondii(T gondii) IgM titer (>= 1:40) (reference values for IgM: negative; <1:40, positive; >= 1:40) and IgG (1:2048) (reference values for IgG: negative; <1:16, equivocal;>= 1:16 - <1:256, positive; >= 1:256). Testing was done by indirect immunofluorescence assay (IFA) in April 2012 in our hospital laboratory. The patient was treated with sulfadiazine, leucovorin, and pyrimethamine. Three months later (July), he returned for follow-up testing. Real-time polymerase chain reaction (PCR) for T. gondii DNA performed by a reference laboratory was negative. One month later (August), Toxoplasma serology was performed by enzyme-linked immunosorbent assay (ELISA) by a different reference laboratory and showed an elevated IgM of 0.95 IU/mL (reference values: negative; <0.55 IU/mL, equivocal; >= 0.55-<0.65 IU/mL, positive; >= 0.65 IU/mL) and a normal level of IgG (<4 IU/mL). At this time, PCR was repeated and was negative. An additional month later (September), the patient's serology studies were performed at a third reference laboratory and showed an elevated IgM of 1.32 IU/mL (reference values: negative; 0.89, equivocal; 0.90 - 1.09, positive; >1.10) and a normal IgG.
引用
收藏
页码:56 / 58
页数:3
相关论文
共 50 条
  • [31] Patient and graft outcomes among kidney transplant recipients who underwent pre-transplant coronary angiography
    Medina, Jason Paul
    Danguilan, Romina A.
    Casasola, Concesa C.
    TRANSPLANTATION, 2016, 100 (07) : S727 - S728
  • [32] Pediatric solid organ transplant recipients positive for severe acute respiratory syndrome coronavirus 2 pre-transplant
    Heald-Sargent, Taylor
    Morrison, Adam
    Verghese, Priya S.
    Chapin, Catherine A.
    Li, Caitlin Naureckas
    TRANSPLANT INFECTIOUS DISEASE, 2024, 26 (03)
  • [33] Toxoplasma chororetinits: value of polymerase chain reaction and intraocular antibody production in a patient with negative anti-Toxopasma gondii serology
    Roels, D.
    Nerinckx, F.
    Leroy, B. P.
    Padalko, E.
    De Schryver, I.
    ACTA OPHTHALMOLOGICA, 2015, 93
  • [34] Pre-transplant Thymic Function Predicts Is Associated With Patient Death After Kidney Transplantation
    Courivaud, Cecile
    Bamoulid, Jamal
    Crepin, Thomas
    Gaiffe, Emilie
    Laheurte, Caroline
    Saas, Philippe
    Ducloux, Didier
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [35] Obliterative bronchiolitis in a 13-year-old pre-transplant cystic fibrosis patient
    Sobande, Patrick O.
    Acton, James D.
    Amin, Raouf S.
    Weiland, Jeanne
    JOURNAL OF CYSTIC FIBROSIS, 2008, 7 (01) : 92 - 94
  • [36] Inferior patient outcomes with peritoneal dialysis as a pre-transplant renal replacement modality.
    Butler, Khayree
    Collins, Michael
    Haririan, Abdolreza
    Weir, Matthew
    Barth, Rolf
    Campos, Luis
    Philosophe, Benjamin
    Bartlett, Stephen
    Cooper, Matthew
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 451 - 451
  • [37] Patient survival after renal transplantation: I. The impact of dialysis pre-transplant
    Cosio, FG
    Alamir, A
    Yim, S
    Pesavento, TE
    Falkenhain, ME
    Henry, ML
    Elkhammas, EA
    Davies, EA
    Bumgardner, GL
    Ferguson, RM
    KIDNEY INTERNATIONAL, 1998, 53 (03) : 767 - 772
  • [38] The Influence of Pre-Transplant Dialysis Modality On Patient and Graft Survival After Kidney Transplantation
    Marcen, R.
    Arias, M.
    Gainza de los Rios, F.
    Morales, J.
    Oppenheimer, F.
    Seron, D.
    Andres, A.
    del Castillo, D.
    Anaya, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 636 - 636
  • [39] REACTIVITY OF PATIENT PRE-TRANSPLANT SERA WITH NON-HLA COATED LUMINEX BEADS
    Ray, Bryan L.
    Hariharan, Jayasree
    Malireddy, Hari
    Gebel, Howard M.
    Bray, Robert A.
    HUMAN IMMUNOLOGY, 2020, 81 : 50 - 50
  • [40] Chronic hepatitis C treatment in a cystic fibrosis patient in the pulmonary pre-transplant stage
    Adan-Merino, L.
    Olveira-Martin, A.
    Prados, C.
    Gea-Rodriguez, F.
    Castillo-Grau, P.
    Martin-Arranz, E.
    Saenz, J. C.
    Segura-Cabral, J. M.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2010, 102 (10) : 587 - 590